| Jill Robinson, RN | |
|
485 N Ks Hwy 2, Anthony, KS 67003-2526 | |
| (620) 914-1200 | |
| Not Available |
| Full Name | Jill Robinson |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Diabetes Educator |
| Location | 485 N Ks Hwy 2, Anthony, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154941680 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WD0400X | Registered Nurse - Diabetes Educator | 74049 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jill Robinson, RN 485 N Ks Hwy 2, Anthony, KS 67003-2526 Ph: (620) 914-1200 | Jill Robinson, RN 485 N Ks Hwy 2, Anthony, KS 67003-2526 Ph: (620) 914-1200 |
News Archive
Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activities and Vygon, a French family-run business that develops, produces and markets medical devices, including catheters and implantable ports for administering chemotherapy treatments, today announce their partnership to develop a new generation of innovative medical devices; mainly for use in chemotherapy. The partnership aims to introduce them to European, the US and Asian markets.
People who use British Sign Language have better reaction times in their peripheral vision, a new study from the University of Sheffield has found.
The National Institutes of Health has awarded $75 million to Charles Drew University of Medicine and Science and three other historically black institutions to establish a medical research consortium to combat health disparities in minority and underserved populations.
Bristol-Myers Squibb Company announced today that it has entered into a clinical collaboration agreement with Tibotec Pharmaceuticals to evaluate the utility of daclatasvir (BMS-790052), Bristol-Myers Squibb's investigational NS5A replication complex inhibitor, in combination with Tibotec Pharmaceuticals' investigational NS3 protease inhibitor, TMC435, for the treatment of chronic hepatitis C virus (HCV).
"Charity chic" is back in style this summer as QVC once again joins forces with the Ovarian Cancer Research Fund to broadcast QVC Presents Super Saturday Live, benefiting OCRF.
› Verified 4 days ago
Mattie Passet, APRN Registered Nurse Medicare: Medicare Enrolled Practice Location: 485 N Ks Hwy 2, Anthony, KS 67003 Phone: 620-914-1200 |